Corifollitropin alfa: A novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation

Women's Health

Volumn 6, Issue 5, 2010, Pages 655-664

  Loutradis, D ^a   Vlismas, A ^a   Drakakis, P ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

controlled ovarian stimulation; corifollitropin alfa; FSH CTP; GnRH antagonist; IVF; rFSH

Indexed keywords

CHORIONIC GONADOTROPIN; CORIFOLLITROPIN ALFA; FERTILITY PROMOTING AGENT; PLACEBO; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ANOVULATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECTOPIC PREGNANCY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY; INJECTION SITE REACTION; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PELVIS PAIN SYNDROME; POSTMARKETING SURVEILLANCE; PREGNANCY RATE; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT;

AREA UNDER CURVE; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILITY AGENTS; FOLLICLE STIMULATING HORMONE, HUMAN; HALF-LIFE; HUMANS; OVULATION INDUCTION; RECOMBINANT PROTEINS;

EID: 77957743723     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.56     Document Type: Review

References (30)

1. Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC: ENGAGE Investigators: a double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the frst seven days of ovarian stimulation using a GnRH antagonist protocol. Hum. Reprod. 24(12), 3063-3072 (2009).
2. Verberg MF, Eijkemans MJ, Heijenen EM et al.: Why do couples drop-out from IVF treatment? A prospective cohort study. Hum. Reprod. 23(9), 2050-2055 (2008).
3. Heijnen EM, Eijkemans MJ, De Klerk C et al.: A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 369(9563), 743-749 (2007).
4. Ulloa-Aguirre A, Timossi C, Damian-Matsumura, Dias J: Role of glycosylation in function of follicle-stimulating hormone. Endocrine 11(3), 205-215 (1999).
5. Fares F: The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim. Biophys. Acta 1760, 560-567 (2006).
6. Creus S, Chaia Z, Pellizzari EH, Cigorraga SB, Ulloa-Aguirre A, Campo S: Human FSH isoforms: carbohydrate complexity as determinant of in vitro bioactivity Mol. Cell Endocrinol. 174(1-2), 41-49 (2001).
7. Perlman S, van den Hazel B, Christiansen J et al.: Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. J. Clin. Endocrinol. Metab. 88(7), 3227-3235 (2003).
8. Klein J, Lobel L, Pollak S et al.: Development and characterization of a long-acting recombinant hFSH agonist. Hum. Reprod. 18(1), 50-56 (2003).
9. Klein J, Lobel L, Pollak S et al.: Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey. Fertil. Steril. 77(6), 1248-1255 (2002).
10. Sugahara T, Sato A, Kudo M et al.: Expression of biologically active fusion genes encoding the common α-subunit and the follicle-stimulating hormone β-subunit. J. Biol. Chem. 271(18), 10445-10448 (1996). (Pubitemid 26145776)
11. Weenen C, Peña JE, Pollak SV et al.: Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with O-linked analogs in female rats. J. Clin. Endocrinol. Metab. 89(10), 5204-5212 (2004).
12. Trousdale RK, Yu B, Pollak SV, Husami N, Vidali hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice. Fertil. Steril. 91(1), 265-270 (2009).
13. Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime I: The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] β-subunit. Endocrinology 126(1), 376-383 (1990).
14. Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh W, Boime I: Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin β-subunit to the follitropin β-subunit. Proc. Natl Acad. Sci. USA 89, 4304-4308 (1992).
15. Daar AS, Merali Z: Infertility and social suffering: the case of ART in developing countries. In: Current Practices and Controversies in Assisted Reproduction. Vayena E, Rowe PJ, Griffn PD (Eds). World Health Organization, Geneva, Switzerland (2002).
16. Boivin J, Bunting L, Collins JA, Nygren KG: International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum. Reprod. 22(6), 1506-1512 (2007).
17. Colins J: Mild stimulation for in vitro fertilization: making progress downward. Hum. Reprod. Update 15(1), 1-3 (2009).
18. Fauser BC, Mannaerts BM, Devroy P, Leader A, Boime E, Baird DT: Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum. Reprod. Update 15(3), 309-321 (2009).
19. Loutradis D, Drakakis P, Vlismas A, Antsaklis A: Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility. Curr. Opin. Investig. Drugs 10(4), 372-380 (2009).
20. LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJ: Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology 131(6), 2514-2520 (1992).
21. Bouloux PM, Handelsman DJ, Jockenhövel F et al.: FSH-CTP study group: frst human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum. Reprod. 16(8), 1592-1597 (2001).
22. R)) by Pen-injector and syringe. Hum. Reprod. 14(7), 1698-1702 (1999).
23. Duijkers IJ, Klipping C, Boerrigter PJ, Machielsen CS, De Bie JJ, Voortman G: Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum. Reprod. 17(8), 1987-1993 (2002).
24. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM: Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J. Clin. Endocrinol. Metab. 89(5), 2062-2070 (2004).
25. Balen AH, Mulders AG, Fauser BC et al.: Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. J. Clin. Endocrinol. Metab. 89(12), 6297-6304 (2004)
26. The corifollitropin alfa dose-fnding study group: a randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum. Reprod. 23(11), 2484-2492 (2008).
27. Fatemi HM, Oberye J, Popovic-Todorovic B, Witjes H, Mannaerts B, Devroy P: Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fertil. Steril. (2010) (Epub ahead of print)
28. The corifollitropin alfa Ensure study group: Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod. Biomed. Online (2010) (In press)
29. deGreef R, Struijs M, de Haan A, Marintcheva-Petrova M, Mannaerts B: Oral dose selection of Org36286 (corifollitropin alfa) using pharmacokinetic and dynamic modelling and simulation. Hum. Reprod. 22(Suppl. 1), 39 (2007).
30. Ledger W, Zandvliet A, Mannaerts B; on behalf of the ENGAGE/ENSURE investigators: Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing ≤60 kg and >60 kg. Hum. Reprod. 24(Suppl. 1), 114 (2009).